Press Releases
Freyr Launches Covid-19 Web Platform for Manufacturers
Freyr, a leading global Regulatory solutions and services company, announces the launch of a powerful web platform for Covid-19 driven with real-time information for manufacturers to make them go to the markets, right in time and support them in...
Clinical Trials
Avalon GloboCare Announces Successful Completion of Phase I Clinical Study of CAR T-Cell Therapy Candidate AVA-001
Avalon GloboCare Corp., a clinical-stage global developer of cell-based technologies and therapeutics, announced it has successfully completed Phase I first-in-human clinical study of its leading Chimeric Antigen Receptor (CAR) T-cell therapy candidate, AVA-001 (National Institute of Health clinical trial...
Press Releases
GSK receives first regulatory approval for Duvroq in Japan for patients with anaemia due to chronic kidney disease
GlaxoSmithKline plc announced the approval of a Japanese New Drug Application (JNDA) by the Ministry of Health, Labour and Welfare for Duvroq (daprodustat) tablets, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for the treatment of patients with anaemia...
Clinical Trials
Samsung Bioepis Initiates Phase 3 Clinical Trial for SB15, Proposed Biosimilar to Eylea
Samsung Bioepis announced the initiation of Phase 3 clinical trial for SB15, the company's proposed biosimilar referencing Eylea® (aflibercept). The Phase 3 clinical trial for SB15 (aflibercept) is a randomised, double-masked, parallel group, multicenter study to compare the efficacy,...
Drug Research
Abbott and Tandem Diabetes Care Advance Development of Integrated Technologies for Future Automated Insulin Delivery Systems
Abbott and Tandem Diabetes Care announced that they have finalized an agreement to develop and commercialize integrated diabetes solutions that combine Abbott's world-leading1 continuous glucose monitoring (CGM) technology with Tandem's innovative insulin delivery systems to provide more options for...
Press Releases
PCI Pharma Services Announces Completion of Biotech Center of Excellence in Philadelphia and Expansions to Biotech Capabilities in Europe
PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, announced the completion of the expansion of its new Biotech Center of Excellence in Philadelphia, Pennsylvania, a major investment that will represent the new U.S. biologics...
Press Releases
Tiziana announces agreement with STC Biologics for manufacturing of TZLS-501
Tiziana Life Sciences plc, a clinical stage biotechnology company developing targeted drugs for cancer, inflammatory diseases and COVID-19, announces the execution of an agreement with STC Biologics, Inc. for GMP manufacturing of TZLS-501, an anti-IL-6 receptor (anti-IL-6R) monoclonal antibody...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read